Eton Pharmaceuticals, Inc. (ETON) Operating cash flow 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$10.5MFY2025 · since FY2018: -$8.1M → $10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.5M | +986.1% |
| FY2024 | $969,000 | -85.8% |
| FY2023 | $6.8M | +41.4% |
| FY2022 | $4.8M | +202.1% |
| FY2021 | -$4.7M | +78.9% |
| FY2020 | -$22.3M | -24.0% |
| FY2019 | -$18.0M | -121.3% |
| FY2018 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice